Changes

Jump to: navigation, search

Cediranib (Recentin)

2 bytes removed, 21:45, 14 January 2019
m
Mechanism of action
=Mechanism of action=
From the [NCI Drug Dictionary]: The maleate salt of an indole ether quinazoline derivative with antineoplastic activities. Competing with adenosine triphosphate, cediranib binds to and inhibits all three vascular endothelial growth factor receptor (VEGFR-1,-2,-3) tyrosine kinases, thereby blocking VEGF-signaling, angiogenesis, and tumor cell growth.
=Preliminary data=
LookupUsers, editors, emailconfirmed
23,852
edits

Navigation menu